All Disease X articles – Page 5
-
NewsCommunity spread drives ongoing measles transmission in Europe
Preliminary data for 2025 show a significant drop in the number of reported measles cases across EU/EEA countries compared with 2024. However, these figures are still twice as high than those reported in 2023.
-
NewsNew dashboard helps predict and plan for disease outbreaks
When infectious diseases surge, response often comes down to whether communities can position the right people and supplies before case counts spike. Researchers have designed a new platform to translate academic disease forecasting into actionable guidance for decision-makers.
-
NewsSix years after COVID-19’s global alarm: Is the world better prepared for the next pandemic?
Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease. As we cross this six-year mark, WHO asks: Is the world better prepared for the next pandemic?
-
NewsNipah virus outbreak: Risk of global threat is low, say experts
The Global Virus Network is monitoring reports of a Nipah virus outbreak in India and emphasizes that such cases, while very concerning and serious, are not unexpected or unprecedented.
-
NewsScientists say these two viruses may become the next public health threats
Two emerging pathogens with animal origins — influenza D virus and canine coronavirus — have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to spread more widely among humans.
-
NewsIn rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to one kind of Chikungunya vaccine, which is no longer available in the U.S.
-
NewsNew platform could develop vaccines faster than ever before
Scientists are optimizing a vaccine-development platform created to accelerate how quickly life-saving vaccines can be designed and deployed during infectious-disease outbreaks such as the COVID-19 pandemic.
-
NewsPreparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at least two years after a booster vaccination.
-
NewsScientists develop novel live-attenuated vaccine that blocks coronavirus transmission with a single intranasal dose
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single intranasal dose. Source: NIAID-RML This colorized transmission electron microscope image shows ...
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Page5
- Next Page